InMed Pharmaceuticals Inc... (INM)
2.67
0.00 (0.00%)
At close: Mar 13, 2025, 1:11 PM
InMed Pharmaceuticals Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 |
| Revenue | 4.6M | 4.14M | 1.09M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 39.66K | 79.46K | 168.42K | 623.37K | 1.74M | 2.76M | 4.23M | 2.09M | 185.61K | 13.77K | 2.44K |
| Cost of Revenue | 3.5M | 2.73M | 545.89K | 197.03K | 183.09K | 93.94K | 92.78K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8.76K | 108.89K | 405.58K | 1.82M | 1.42M | 3.19M | 1.2M | 90.02K | 17.16K | 17.02K |
| Gross Profit | 1.1M | 1.4M | 543.55K | -197.03K | -183.09K | -93.94K | -92.78K | n/a | n/a | n/a | n/a | n/a | n/a | 39.66K | 70.71K | 59.53K | 217.79K | -80.56K | 1.34M | 1.04M | 892.2K | 95.59K | -3.39K | -14.58K |
| Operating Income | n/a | -8.18B | -13.7M | -9.92M | -8.74M | -10.36M | -6.78M | -3.44M | -1.84M | -3.45M | -1.15M | -49.19K | -168.72K | -387.56K | -411.4K | -777K | -1.27M | -1.77M | -1.18M | -1.99M | -1.24M | -1.28M | -2.75M | -4.25M |
| Interest Income | 527.9K | 492.44K | 96.09K | 16.02K | 125.89K | 330.44K | 69.55K | n/a | n/a | n/a | n/a | 10.45 | 16.71 | -0.39 | -0.05 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -7.67M | -7.93M | -18.6M | -10.2M | -8.68M | -10.1M | -6.71M | -3.44M | -1.84M | -3.46M | -1.15M | -46.74K | -189.92K | -461.35K | -515.65K | -1.05M | -1.5M | -1.79M | -1.2M | -2.75M | -1.51M | -1.28M | -2.79M | -2.29M |
| Net Income | -7.68M | -7.95M | -18.6M | -10.2M | -8.94M | -10.01M | -6.71M | -3.44M | -1.84M | -3.46M | -1.15M | -46.74K | -189.92K | -325.47K | -334.79K | -1.06M | -922.26K | -1.87M | -1.27M | -2.78M | -1.52M | -1.23M | -2.71M | -4.27M |
| Selling & General & Admin | 5.25M | 5.85M | 6.87M | 4.48M | 3.5M | 6M | 5.17M | 2.79M | 1.48M | 2.62M | 1.09M | 46.75K | 151.57K | 314.36K | 300.73K | 536.37K | 1.17M | 1.31M | 2.26M | 2.58M | 1.84M | 995.66K | 902.67K | 3.91M |
| Research & Development | 3.77M | 3.73M | 7.28M | 5.34M | 5.2M | 4.3M | 1.52M | 573.72K | 292.84K | 759.85K | 57.87K | n/a | 17.03K | n/a | 118.42K | 116.94K | 236.23K | 212.64K | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Expenses | n/a | -308.94K | 185.66K | 120.87K | 161.97K | 94.72K | -0.00 | 75.22K | 67.41K | 75.76K | -900.75 | n/a | n/a | -73.79K | -104.25K | 237.9K | 83.24K | 169.63K | 255.18K | 453.18K | 295.85K | 380.7K | 1.85M | 329.67K |
| Operating Expenses | 9.02B | 9.78M | 14.34M | 9.94M | 8.87M | 10.39M | 6.69M | 3.44M | 1.84M | 3.46M | 1.15M | 46.75K | 168.6K | 427.21K | 482.11K | 836.53K | 1.49M | 1.69M | 2.52M | 3.03M | 2.13M | 1.38M | 2.75M | 4.24M |
| Interest Expense | n/a | n/a | 96.09K | 360.35K | 18.62K | n/a | n/a | 495.17 | 47.92 | 3.53K | 1.69K | 10.45 | 16.71 | 11.7K | 27.63K | 5.9K | 230.1K | 17.47K | 20.14K | 760.73K | 267.57K | n/a | 32.91K | n/a |
| Selling & Marketing Expenses | -5.25B | n/a | n/a | n/a | 474.94K | 706.23K | n/a | 844.27K | 112.64K | 498.44K | 22.65K | n/a | n/a | 27.36K | 63.45K | 97K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 16.01B | 12.51M | 14.88M | 9.94M | 8.87M | 10.39M | 6.78M | 3.44M | 1.84M | 3.46M | 1.15M | 46.75K | 168.6K | 427.21K | 490.87K | 945.42K | 1.89M | 3.51M | 3.93M | 6.22M | 3.34M | 1.47M | 2.77M | 4.26M |
| Income Tax | 7.1K | 13.1K | 4.81M | 360.35K | 18.62K | -262.1K | -69.54K | 495.17 | 47.92 | 3.53K | 1.69K | -2.46K | 21.18K | -73.79K | -104.25K | 791.78K | -347.85K | 99.59K | 99.26K | 816.12K | 277.22K | -50.37K | -40.34K | 15.51K |
| Shares Outstanding (Basic) | 7.62M | 2.45M | 560.75K | 268.79K | 208.83K | 207.09K | 172.67K | 108.43K | 72.97K | 55.87K | 41.93K | 40.84K | 40.84K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Shares Outstanding (Diluted) | 7.62M | 2.45M | 560.83K | 268.79K | 208.83K | 207.09K | 172.67K | 108.43K | 72.97K | 55.87K | 41.93K | 40.84K | 40.84K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EPS (Basic) | -1.01 | -4.3 | -42.69 | -47.06 | -58.11 | -64.01 | -49.35 | -41.26 | -32.58 | -76.83 | -29.31 | -1.2 | -4.65 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EPS (Diluted) | -1.01 | -4.31 | -42.7 | -47.06 | -58.11 | -64.01 | -49.35 | -41.26 | -32.58 | -76.83 | -29.31 | -1.2 | -4.65 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA | -7.06M | -10.83M | -17.26M | -9.8M | -8.58M | -10.26M | -6.69M | -3.36M | -1.77M | -3.38M | -1.15M | -46.75K | -168.59K | -252.04K | -341.9K | -608.24K | -1.19M | -973.42K | -920.79K | -1.54M | -946.79K | -900.07K | -906.07K | -2.04M |
| Depreciation & Amortization | 604.52K | 596K | 511.79K | 197.03K | 183.09K | 94.72K | 89.6K | 75.22K | 67.41K | 75.76K | 40.30 | 2.44K | 133.71 | 135.52K | 69.5K | 168.76K | 83.24K | 169.63K | 252.49K | 426.34K | 295.85K | 380.7K | 1.85M | 2.22M |